IL6 and metabolic dysfunction-associated steatotic liver disease: Using the same strategy incorporating 5 cytokine/inflammation markers (CCL2, CCL3, TNFα, IL6 and IL8) hierarchic cluster analysis could distinguish lean, NAFLD subgroups and decompensated NASH cirrhotics although more patients were misclassified (Fig 3B).